XML 42 R33.htm IDEA: XBRL DOCUMENT
v3.20.4

C STOCKHOLDERS EQUITY (Details Narrative) - USD ($) |  | 1 Months Ended | 3 Months Ended | 9 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 10, 2018 | Jun. 25, 2020 | May 31, 2020 | May 26, 2020 | May 08, 2020 | Apr. 30, 2020 | Apr. 20, 2020 | Mar. 31, 2020 | Jan. 31, 2020 | Jan. 23, 2020 | Dec. 31, 2019 | Oct. 10, 2018 | Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Jun. 29, 2020 | Apr. 06, 2020 | Sep. 30, 2019 | Jan. 09, 2019
Prepaid expenses |  |  |  |  |  |  |  |  |  |  |  |  | $ 242,000 |  | $ 242,000 |  |  |  | $ 230,000 |
Total compensation expense |  |  |  |  |  |  |  |  |  |  |  |  | $ 901,000 |  |  |  |  |  |  |
Common stock shares issued |  |  |  |  |  |  |  | 630,500 |  |  | 606,395 |  | 38,522,236 |  | 38,522,236 |  |  |  | 35,231,776 |
Public offering price per share |  |  |  |  |  |  |  | $ 12.22 | $ 9.07 |  | $ 9.07 |  |  |  |  |  |  |  |  |
Proceeds from public offering |  |  | $ 1,100,000 |  |  |  |  | $ 7,100,000 | $ 800,000 |  | $ 5,000,000.0 |  |  |  | $ 184,990 | $ 234,997 |  |  |  |
Additional shares of common stock |  |  |  |  |  |  |  | 94,575 | 90,959 |  | 90,959 |  |  |  |  |  |  |  |  |
Incremental cost |  |  |  |  |  |  |  |  |  |  |  |  | $ 664,000 |  |  |  |  |  |  |
Interest expense |  |  |  |  |  |  |  |  |  |  |  |  | 6,000 |  | 6,000 |  |  |  |  |
Shares to be issued |  |  |  |  |  |  |  |  |  |  |  |  | $ 110,000 |  | $ 110,000 |  |  |  |  |
Performance-based stock options granted |  |  |  |  |  |  |  |  |  |  |  |  | 2,559,000 | 3,268,362 | 2,561,500 | 3,268,862 |  |  |  |
Common stock valued |  |  |  |  |  |  |  |  |  |  |  |  | $ 385,223 |  | $ 385,223 |  |  |  | $ 352,318 |
Fair value of warrant |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 805,753 | $ 0 |  |  |  |
Warrants expired |  |  |  |  |  |  |  |  |  |  |  |  | 16 | 26,922 | 1,000 | 29,322 |  |  |  |
Series V Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock price per share |  | $ 13.75 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expiration date description |  |  |  | extended the expiration date of the Series V warrants from May 28, 2020 to June 25, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrant |  | $ 211,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expired |  | 135,963 |  | 810,127 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercised |  |  |  | 674,164 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loss on derivatives |  |  |  | $ 560,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series V Warrants [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock price per share |  |  |  | $ 19.75 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series V Warrants [Member] | Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock price per share |  |  |  | $ 13.75 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series N Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Incremental cost |  |  |  |  |  |  |  |  |  | $ 22,000 |  |  |  |  |  |  |  |  |  |
Expiration date description |  |  |  |  |  |  |  |  |  | expiration date of the Series N warrants was extended to February 18, 2021 |  |  |  |  |  |  |  |  |  |
Series UU warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Incremental cost |  |  |  |  |  |  |  |  |  |  |  |  | $ 6,000 |  | $ 6,000 |  |  |  |  |
Expiration date description |  |  |  |  | extended from June 11, 2020 to December 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  |  | 93,593 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series YY Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant issued |  |  |  |  |  |  |  |  |  |  |  |  | 101,839 |  | 101,839 |  |  |  |  |
Fair value of warrant |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 177,000 |  |  |  |  |
Series XX Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock price per share |  |  |  |  |  |  |  |  |  |  |  |  | $ 18.00 |  | $ 18.00 |  |  |  |  |
Warrant issued |  |  |  |  |  |  |  |  |  |  |  |  | 461,953 |  | 461,953 |  |  |  |  |
Fair value of warrant |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 629,000 |  |  |  |  |
Series S Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock price per share |  |  |  |  |  |  |  |  |  |  |  | $ 31.25 |  |  |  |  |  |  |  |
Warrants expired |  |  |  |  |  |  |  |  |  |  |  | 327,729 |  |  |  |  |  |  |  |
Series DD Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock price per share | $ 4.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expired | 1,360,960 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series EE Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock price per share | $ 4.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expired | 1,360,960 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consulting Agreements [Meember] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total expense |  |  |  |  |  |  |  |  |  |  |  |  | $ 276,000 | $ 177,000 | $ 623,000 | $ 688,000 |  |  |  |
Consultants [Meember] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10,000 |  |  |  |  |
Consultants [Meember] | Restricted Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued for service, shares |  |  |  |  |  |  |  |  |  |  |  |  | 14,811 | 20,825 | 47,750 | 161,058 |  |  |  |
Weighted average grant date fair value |  |  |  |  |  |  |  |  |  |  |  |  | $ 16.41 | $ 5.62 | $ 11.60 | $ 3.37 |  |  |  |
Ergomed [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares held |  |  |  |  |  |  |  |  |  |  |  |  | 110,521 |  | 110,521 |  |  |  |  |
Ergomed [Member] | SPA [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted shares of common stock issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 | 100,000 |  | 500,000
Common stock valued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 800,000 | $ 1,000,000.0 |  | $ 1,300,000
Restricted shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 500,000 | 50,000 |  |
2020 Non-Qualified Stock Option Plans [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock price per share |  |  |  |  |  |  |  |  |  |  |  |  | $ 10.93 |  | $ 10.93 |  |  |  |  |
Aggregate fair value |  |  |  |  |  |  | $ 7,881,120 |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value price per share |  |  |  |  |  |  | $ 4.12 |  |  |  |  |  |  |  |  |  |  |  |  |
Performance-based stock options granted |  |  |  |  |  | 1,872,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase shares of common stock |  |  |  |  |  |  |  |  |  |  |  |  | 3,600,000 |  | 3,600,000 |  |  |  |  |

X
- References No definition available. + Details
Name: | cvm_AdditionalSharesOfCommonStock
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | cvm_AggregateFairValue
Namespace Prefix: | cvm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_CompensationExpenseOther
Namespace Prefix: | cvm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_ExpirationDateDescription
Namespace Prefix: | cvm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_FairValuePricePerShare
Namespace Prefix: | cvm_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. + References No definition available. + Details
Name: | cvm_PrepaidExpenses
Namespace Prefix: | cvm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and + References No definition available. + Details
Name: | cvm_RestrictedSharesIssued
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and + References No definition available. + Details
Name: | cvm_RestrictedSharesOfCommonStockIssued
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | cvm_WarrantIssued
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | cvm_WarrantsIssued
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of subscription receivable from investors who have been allocated common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of common stock held in a trust that has been set up specifically to accumulate stock for the sole purpose of distribution to participating employees but not yet earned. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 25 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=109244457&loc=d3e16701-113920 + Details
Name: | us-gaap_CommonStockSharesHeldInEmployeeTrustShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Total costs of sales and operating expenses for the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_CostsAndExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cost recognized for passage of time related to defined benefit plan. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (h)(2) -URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -SubTopic 20 -Section 55 -Paragraph 17 -URI http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -SubTopic 20 -Section 50 -Paragraph 6 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920 + Details
Name: | us-gaap_DefinedBenefitPlanInterestCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of decrease in the fair value of derivatives recognized in the income statement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b)(1) -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959 + Details
Name: | us-gaap_DerivativeLossOnDerivative
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section 25 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of the cost of borrowed funds accounted for as interest expense. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (210.5-03(11)) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260 + Details
Name: | us-gaap_InterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of options issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586 + Details
Name: | us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationOptionsIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of non-option equity instruments exercised by participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares authorized for issuance under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(4) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gross number of share options (or share units) granted during the period. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=cvm_SeriesVWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=cvm_SeriesNWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=cvm_SeriesUUWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=cvm_SeriesYYWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=cvm_SeriesXXWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=cvm_SeriesSWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=cvm_SeriesDDWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=cvm_SeriesEEWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=cvm_ConsultingAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvm_ConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvm_ErgomedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=cvm_SPAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=cvm_TwoThousandTwentyNonQualifiedOptionsPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |